<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366823">
  <stage>Registered</stage>
  <submitdate>31/07/2014</submitdate>
  <approvaldate>8/08/2014</approvaldate>
  <actrnumber>ACTRN12614000853640</actrnumber>
  <trial_identification>
    <studytitle>Methoxyflurane analgesia during local anaesthetics injections.</studytitle>
    <scientifictitle>Evaluation of the safety of use of methoxyflurane analgesia during local anaesthetics injections in in patients awaiting minor surgical procedures.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>analgesia</healthcondition>
    <healthcondition>minor surgeries</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Methoxyflurane will be given orally to participants before and during injection of local anaesthetic Ropivacaine. Methoxyflurane is self-administered by inhalation through a hand-held whistle shaped inhaler marketed as Penthrox 'Registered Trademark'. All patients are assessed by an anesthesiologist before commencement of the study. Patients are instructed how to use Penthrox 'Registered Trademark' with advice to occlude the aerating hole if they felt they required more analgesia. Pulse oximetry is used throughout the procedure. The anesthesiologist charges the whistle by emptying the entire contents of the bottle of methoxyflurane provided (3 mL) into the bottom of the whistle. Patients are instructed to take some slow easy breaths of the vapour and when they were comfortable with the aroma, take 10 large full breaths, inhaling and exhaling through the whistle. The injection of LA lasts 1 minute and commences after the second breath on Penthrox 'Registered Trademark'.  Participants can inhale through the Penthrox 'Registered Trademark' more than 10 times if they feel the need. </interventions>
    <comparator>no control treatment</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Pain levels on the numerical Wong-Baker Faces pain rating scale.</outcome>
      <timepoint>1 min after injection of local anaesthetics</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Sedation scores using the Ramsay sedation scale.</outcome>
      <timepoint>at 1 min after local anaesthetics injection</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Either sex, more than 18 years old, awaiting minor surgical procedures that can be done under local anaesthetics.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Allergies to methoxyflurane or local anaesthetics</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1</phase>
    <anticipatedstartdate>1/09/2009</anticipatedstartdate>
    <actualstartdate>1/09/2009</actualstartdate>
    <anticipatedenddate>30/09/2009</anticipatedenddate>
    <actualenddate>30/09/2009</actualenddate>
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Peninsula health</primarysponsorname>
    <primarysponsoraddress>PO box 52
Frankston
VIC 3199
</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This pilot study assesses the feasablity and safety of inhaled methoxyflurane in ambulatory plastic surgery procedures as an alternative to intravenous sedation. </summary>
    <trialwebsite />
    <publication>Article submitted for publication, in review.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Peninsula Health ethics committee</ethicname>
      <ethicaddress />
      <ethicapprovaldate>1/09/2009</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>David Hunter-Smith</name>
      <address>Peninsula Health - department of Plastics and Reconstructive surgery
PO box 52
Frankston
Vic 3199</address>
      <phone>+613 9784 8416</phone>
      <fax />
      <email>dhuntersmith@gmail.com</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alexandra Rizzitelli</name>
      <address>Peninsula Health - department of surgery

PO box 52
Frankston
Vic 3199</address>
      <phone>+613 9784 8416</phone>
      <fax />
      <email>arizzitelli@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alexandra Rizzitelli</name>
      <address>Peninsula Health - department of surgery

PO box 52
Frankston
Vic 3199</address>
      <phone>+613 9784 8416</phone>
      <fax />
      <email>arizzitelli@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Alexandra Rizzitelli</name>
      <address>Peninsula Health - department of surgery

PO box 52
Frankston
Vic 3199</address>
      <phone>+613 9784 8416</phone>
      <fax />
      <email>arizzitelli@phcn.vic.gov.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>